Mustang Reconciled Depreciation from 2010 to 2024

MBIO Stock  USD 0.26  0.01  4.00%   
Mustang Bio Reconciled Depreciation yearly trend continues to be very stable with very little volatility. Reconciled Depreciation is likely to drop to about 1.9 M. During the period from 2010 to 2024, Mustang Bio Reconciled Depreciation quarterly data regression pattern had sample variance of 1.3 T and median of  2,000. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2018-03-31
Previous Quarter
367 K
Current Value
363 K
Quarterly Volatility
222.2 K
 
Covid
Check Mustang Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mustang main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 9 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 99.16. Mustang financial statements analysis is a perfect complement when working with Mustang Bio Valuation or Volatility modules.
  
This module can also supplement various Mustang Bio Technical models . Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.

Latest Mustang Bio's Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of Mustang Bio over the last few years. It is Mustang Bio's Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mustang Bio's overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

Mustang Reconciled Depreciation Regression Statistics

Arithmetic Mean912,608
Geometric Mean47,419
Coefficient Of Variation124.88
Mean Deviation1,008,996
Median2,000
Standard Deviation1,139,664
Sample Variance1.3T
Range3M
R-Value0.87
Mean Square Error335.2B
R-Squared0.76
Significance0.000023
Slope222,214
Total Sum of Squares18.2T

Mustang Reconciled Depreciation History

20241.9 M
20232.7 M
2022M
20212.3 M
20201.8 M
20191.4 M
2018630 K

About Mustang Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Mustang Bio income statement, its balance sheet, and the statement of cash flows. Mustang Bio investors use historical funamental indicators, such as Mustang Bio's Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Although Mustang Bio investors may use each financial statement separately, they are all related. The changes in Mustang Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Mustang Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Mustang Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Mustang Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Reconciled Depreciation2.7 M1.9 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Mustang Stock analysis

When running Mustang Bio's price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
CEOs Directory
Screen CEOs from public companies around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.00)
Revenue Per Share
(0)
Return On Assets
(0.58)
Return On Equity
(2.22)
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.